This TikTok peptide therapy advice needs a reality check

What did @balancewithd actually say?

At two weeks into GHK-Cu (copper peptide) supplementation, the creator reported drier skin, a duller complexion, and dry hair, and offered an explanation: the body prioritizes internal repair over external appearance first. "When something like a peptide works systemically, your body is not gonna prioritize the outside first." She framed the temporary skin decline as expected and said to wait for weeks three and four before judging results.

To her credit, she didn't panic or oversell. She reported negative side effects openly, which is more than most peptide content creators do. But the explanation she offered for why those side effects are happening is where things get scientifically shaky.

Does the science back this up?

The "systemic prioritization" framework she describes, where the body diverts resources inward before improving outward, is not a documented pharmacological mechanism for GHK-Cu. It sounds logical, but it isn't grounded in how this peptide actually works.

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide that has been studied primarily in skin biology. Pickart et al. (2015, Journal of Aging Research) documented its role in stimulating collagen synthesis, wound repair signaling, and antioxidant enzyme activity. Notably, nearly all of its studied mechanisms are local and topical, not systemic resource-allocation effects. A 2012 review by Pickart and Margolina in the same journal found that GHK-Cu promotes skin repair by upregulating matrix metalloproteinases and growth factors at the application site. There is no peer-reviewed evidence that oral or injectable GHK-Cu triggers a body-wide triage system that temporarily degrades skin to fund internal repair.

What did they get wrong (or right)?

The creator got the side effect reporting right. Dry skin and dull hair are worth noting and worth sharing publicly. That kind of transparency is genuinely useful.

What she got wrong is the mechanistic explanation. "It's gonna get worse before it gets better" is a real phenomenon in some clinical contexts, like retinoid purging in dermatology, but that process has a documented biological basis (accelerated cell turnover). Attributing temporary skin dullness to GHK-Cu "pulling resources inward" is speculative framing with no scientific basis.

There's also an important alternative explanation she didn't consider: the side effects she's describing, dryness, pallor, hair dryness, could reflect something entirely unrelated to GHK-Cu's mechanism. They could indicate a skin barrier disruption, a reaction to a carrier solution, a formulation issue with a compounded product, or a coincidental change in environment or routine. Without ruling those out, attributing the changes to a systemic healing response is premature.

• GHK-Cu has real evidence behind it for wound repair and collagen signaling (Pickart, 2015)
• The "internal triage" explanation is not documented in the literature
• Compounded peptide formulations vary significantly in quality and excipients

What should you actually know?

GHK-Cu has one of the more legitimate evidence bases in the peptide space, but most of that evidence comes from in vitro studies and topical applications, not systemic administration. The leap from "this peptide stimulates collagen in cell culture" to "taking it systemically will improve my skin after a temporary dip" is significant and not yet supported by clinical trials in humans.

If you're experiencing unexpected skin or hair changes after starting any peptide, the correct move is not to trust a narrative and wait. It's to consult a clinician, review the specific formulation you're using, and consider whether the product itself, not the peptide's mechanism, could be responsible. Compounded peptides are not standardized products, and carrier agents, preservatives, and peptide purity all vary by compounding pharmacy. Cheung et al. (2023, Dermatology and Therapy) noted that adverse skin reactions to compounded cosmeceutical and peptide formulations are underreported and often attributed to the active compound when the culprit is the vehicle.

"I trust the process" is not a substitute for informed monitoring, especially when physical symptoms are present.